(Q43009548)

12 November 2017

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism (English)

1 reference

12 November 2017

1 reference

1

1 reference

12 November 2017

Florencia Steinvarcel

2

1 reference

12 November 2017

Alois Osorio

3

1 reference

12 November 2017

Cristina Ros

4

1 reference

12 November 2017

Juan Balasch

5

1 reference

12 November 2017

language of work or name

1 reference

1 October 2010

1 reference

Gynecological Endocrinology

12 November 2017

1 reference

12 November 2017

26

1 reference

12 November 2017

10

1 reference

12 November 2017

736-742

1 reference

Androgen excess in women: experience with over 1000 consecutive patients

12 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2010.481025

10.3109/09513590.2010.481025

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference